INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide, with prevalence high in industrialized and low-and middle-income countries (2) . Between 1999 and 2004, only ~8% (1 in 12) of US adults had a low burden of cardiovascular risk factors, and similar levels of cardiovascular risk are reported in Spain (2) . There is thus vast untapped potential for the prevention of atherosclerosis and CVD (3) , prompting the promotion of lifestyle-modification strategies as a first-line approach. However, it is important to carefully evaluate how modifying specific parameters influences cardiovascular risk.
Current guidelines identify 4 main primary risk factors for cardiovascular health (CVH): hypertension (blood pressure ≥140/90 or medication with blood-pressurelowering drugs), overweight or obesity (BMI ≥25), smoking, and physical inactivity (≤150 min/week) (3) . However, a number of secondary risk factors also correlate closely with cardiovascular risk, such as waist circumference and diabetes mellitus, and there is moderate evidence for and influence of lipid profile (3) . All of these risk factors are strongly influenced by diet, which like other lifestyle factors can be modified to either increase or reduce cardiovascular risk; for example, daily intake of fruit and vegetables lowers the risk of death from all causes, particularly CVD (3). Physical activity/exercise training, a healthy diet, weight loss, smoking cessation, and control of blood pressure (BP) and blood lipids and glucose are general strategies for cardiac rehabilitation programs. Based on these parameters (BP, exercise, weight, diet, and tobacco) the Fuster BEWAT Score (FBS) (2) has been designed as a tool for evaluating changes in healthy behaviors in relation to CVH.
Prominent among other possible cardiovascular risk indicators are markers of inflammation, and IL-1β in particular has been linked to several steps in the development of atherosclerosis, heart disease, and type II diabetes [Li] . The cytokines IL-1β and IL-18 are activated by the inflammasome complex, a multiprotein complex composed of an intracellular sensor, typically a Nod-like receptor (NLR), the precursor procaspase-1, and the adaptor ASC (apoptosis-associated speck-like protein containing a CARD) (5) .
In the present study, we compared cardiovascular risk factors and diet between men undergoing cardiac rehabilitation after acute myocardial infarction (AMI) and a control group of men with no history of CVD. The cardiovascular risk profile of both participant groups was assessed by Framingham 10 year risk score (FRS) and the FBS.
RESULTS
Anthropometric parameters are listed in Table 1 . AMI patients had a higher mean BMI, (30.1±4.5 kg/m 2 ) than the control group (28.2 ± 4.1 kg/m 2 ), with a medium effect size (Cohen's d, 0.48). Similarly, the AMI group had a higher mean waist circumference (107.1 ± 13.2 cm versus 102.6 ± 11.9 cm), with a low effect size (Cohen's d, 0.35).
However, a high percentage of the control group had a high BMI (overweight 48%, obesity 28.4%). Interestingly, the control group had higher systolic BP (144.8 ± 23.6 mmHg versus 117.3 ± 16 mmHg) and diastolic BP (83.7 ± 11.7 mmHg versus 71.8 ± 9 mmHg), with high effect sizes. This difference was reflected in 55% of control group members having systolic BP >140 mmHg, compared with 42% of the AMI group.
Moreover, FRS-predicted CVR in the control group (13.5 ± 8.9%) was higher than in the AMI group (9.5 ± 6.9%). Cardiovascular risk is linked to several biochemical parameters. No significant between-group differences were found for glucose, triglycerides, or VLDL-cholesterol.
In contrast, levels of total cholesterol and LDL-cholesterol were higher in the control group (195.5 ± 36.6 mg/dL and 130.2 ± 34.5 mg/dL) than the AMI group (150.6 ± 42 mg/dL and 88.4 ± 30.9 mg/dL), with a high effect size (Table 2 ). Control subjects also had higher levels of HDL-cholesterol (47.4 ± 13 mg/dL versus 40.2 ± 10.2 mg/dL), with a moderate effect size (Table 2 ). These differences translated into higher cardiovascular risk estimates for the control group, with 27% of control group members having total cholesterol >220 mg/dL, versus 4% for the AMI group; similarly, 30% of control group individuals had LDL-cholesterol >150md/dL, versus 3% of the AMI group.
FBS was significantly higher in the AMI group than in the control group, both for overall score (AMI group, 8.73 ± 1.86 versus control group, 5.67 ± 2.64) and for 4 of the 5 individual score variables (Table 3 ). The control group had a higher score than the AMI group only for weight. Between-group differences were associated with high effect size for overall FBS and for 3 of the individual variables, whereas effect size was moderate for diet and weight (Table 3) .
Estimated dietary intake of calories and micronutrients is summarized in Table S1 . The control group showed an overall higher intake than the AMI group. For example, intake of calories, lipids, and cholesterol was significantly higher in the control group, with differences generally associated with a moderate effect size, whereas higher estimated intake of saturated fats and carbohydrates in the control group was associated with a high effect size. The control group also had a higher estimated intake of protein, monounsaturated fat, and polyunsaturated fat, but with a low effect size. Between-group differences in the estimated intake of other mineral and vitamin nutrients were small and associated with a small effect size (Tables S2 and S3 ). The most notable difference was sodium intake, which was higher in the control group (2734.8 ± 946.9 mg) than in the AMI group (2463.2 ± 1009.1 mg) (Table S2 ).
The pathophysiology of coronary artery disease has been linked to lipid peroxidation and other indicators of oxidative stress, autophagy impairment, and inflammatory markers such as IL-1β (4-6). The AMI group showed higher levels of oxidative stress and IL-1β, with a high effect size (Table 2) . Despite the more favorable values in the AMI group for several blood biochemical markers, likely due to the rehabilitation program, oxidative stress and inflammation levels remained high during the observational period of this study. Consistent with this, the AMI group showed higher levels of NLRP3 gene expression and lower levels of the autophagy-related gene MAP-LC3 than the control group (Figure 1 ), suggesting an implication of both genes in the pathophysiology of coronary artery disease. However, this observation should be interpreted with caution because the AMI patients were receiving antihypertensive medication. Risk factors for systemic hypertension include obesity, excessive sodium intake, and alcohol consumption (9). An unhealthy diet accompanied by high sodium ingestion can increase BMI and hypertension, and restriction of daily sodium intake to 2400 mg is generally viewed as beneficial (9), with the American Heart Association recommending a daily intake of no more than 1500 mg.
In the present study, the control group had a significantly higher sodium intake than the (3) suggests that FBS could be a more accurate predictor of cardiovascular risk. Interestingly, despite the controlled diet of the AMI group, these participants had higher IL-1β concentrations than the control group, revealing a systemic inflammation that was not ameliorated by surgery and normalization of CVD biomarkers. The higher estimated intake of cholesterol and saturated fat among the control group participants anticipates a risk situation which could lead to inflammasome activation and associated IL-1β release. Consistent with the IL-1β data, the AMI group also showed increased gene expression of NLRP3.
The NLRP3 inflammasome is inhibited by autophagy, a biological process involving lysosomes that preserves the balance between synthesis, degradation and recycling of cellular components and which is therefore essential for cell function and survival. This observation led to interest in the potential of autophagy-inducing treatments. The mechanisms by which autophagy regulates inflammasome activation are still unknown; however, it is well known that autophagy limits IL-1β production and release (6).
Autophagy is an important mechanism in the maintenance of cardiac homeostasis, and accumulating evidence suggests that reduced autophagy is associated with heart failure 
INNOVATION
Inflammasome has been indicated as being in the pathophysiology of CVDs and metabolic diseases with a high cardiovascular component such as obesity and type II diabetes and it has been suggested that oxidative stress and autophagy impairment could be among the factor responsible for NLRP3-inflammasome activation. This is an interesting issue that warrants consideration to design new experiments in order to gain further insight into its potential therapeutic applications, given that inflammasome activation is a modifiable factor. The results described in this article may serve as a new way to AMI patient management and a biomarker to predict the risk repetition.
Furthermore, non-healthy life style can to induce a NLRP3-inflammasome dependent cardiovascular risk factor. 
Notes

Outcome measures
Patients were assigned to the AMI group 6 months after AMI. The primary outcome measure was the FRS, calculated as the summation of all Framingham risk-related factors: age, sex, LDL-C or total cholesterol, HDL-C, BP, and smoking status. We also calculated the mean difference in FBS between the control and AMI groups to monitor progress toward health in the AMI patients (2) . The FBS categorizes the 5 individual variables (BP, exercise, body weight, alimentation, and tobacco smoking) on a 15-point simple ordinal scale to evaluate healthy habits and non-laboratory-based CVH factors.
For each participant, each variable is graded (0, 1, 2, or 3) according to its approximation to international guidelines for cardiovascular risks and habits, with 3 being the optimal value (2).
General and anthropometric data:
For all participants, data collected included age, height, weight, body mass index, abdominal waist circumference, hip circumference, Biochemical parameters: Serum levels of glucose, total cholesterol, triglycerides, HDL, LDL, and VLDL were assayed by routine analytical methods.
IL-1β:
Serum levels of IL-1β were assayed in duplicate using commercial ELISA kits (Biosource).
Lipid peroxidation: Lipid peroxidation in mononuclear blood cells was estimated from the accumulation of lipoperoxides using a commercial kit (Cayman Chemical, Ann
Arbor, Michigan, USA). Thiobarbituric acid reactive substances (TBARS) were assessed from the levels of malondialdehyde (nmol malondialdehyde/mg protein). 
Real-time quantitative PCR (qPCR):
Statistical analysis
Statistical analyses were performed with SPSS 23 and G * Power 3.1.9.2. Statistical significance of differences was assigned at p < 0.05 and statistical power at 1-β=0.80. experiments. *P < 0.001 between patients and controls. Tables   Table 3: FBS in male Tables   Table 4 This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
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